AstraZeneca Pharma India Limited has informed the Exchange about General Updates
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
AstraZeneca Pharma India has filed a routine regulatory compliance notice informing stock exchanges about the Key Managerial Personnel authorized to determine materiality of events under SEBI Listing Regulations. Three senior officials are designated: the Managing Director, CFO & Director, and the Company Secretary & Compliance Officer. All three are jointly and/or severally authorized. Contact details and email addresses are provided for each official. This filing updates the exchanges on the authorized signatories for material disclosure determinations.
No direct impact on stock price or operations. This is a standard administrative filing updating contact information for regulatory disclosure purposes.